Evidence map›Paper›PMID 33332384›Full record

ArticlePLoS genetics2020

Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes.

Anna Byrjalsen, Thomas V O Hansen, Ulrik K Stoltze, Mana M Mehrjouy, Nanna Moeller Barnkob, Lisa L Hjalgrim, René Mathiasen, Charlotte K Lautrup, Pernille A Gregersen, Henrik Hasle and 13 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
20.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Integrated Germline and Somatic Molecular Profiling to Detect Cancer Predisposition Has a High Clinical Impact in Poor-Prognosis Pediatric Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 1 country.

Anna ByrjalsenDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-3470-5995
Thomas V O HansenDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Ulrik K StoltzeDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-5862-3292
Mana M MehrjouyDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-4681-3723
Nanna Moeller BarnkobDepartment of Health Technology, Technical University of Denmark, Copenhagen, Denmark.ORCID 0000-0003-2932-5063
Lisa L HjalgrimDepartment of Paediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-5186-3365
René MathiasenDepartment of Paediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Charlotte K LautrupDepartment of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
Pernille A GregersenDepartment of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0003-3424-0590
Henrik HasleDepartment of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0003-3976-9231
Peder S WehnerDepartment of Paediatric Hematology and Oncology, H. C. Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.ORCID 0000-0003-3881-5179
Ruta TuckuvieneDepartment of Paediatrics and Adolescent Medicine, Aalborg University Hospital, Aalborg, Denmark.
Peter Wad SackettDepartment of Health Technology, Technical University of Denmark, Copenhagen, Denmark.ORCID 0000-0003-3628-2807
Adrian O LaspiurDepartment of Health Technology, Technical University of Denmark, Copenhagen, Denmark.
Maria RossingCenter for Genomic Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-8396-761X
Rasmus L MarvigCenter for Genomic Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-5267-3173
Niels TommerupDepartment of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
Tina Elisabeth OlsenDepartment of Pathology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-9471-472X
David ScheieDepartment of Pathology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Ramneek GuptaDepartment of Health Technology, Technical University of Denmark, Copenhagen, Denmark.ORCID 0000-0001-6841-6676
Anne-Marie GerdesDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Kjeld SchmiegelowDepartment of Paediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-0829-4993
Karin WadtDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-2882-6798
Copenhagen University Hospital · DKTechnical University of Denmark · DKAalborg University Hospital · DKAarhus University Hospital · DKUniversity of Copenhagen · DKOdense University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHistorically, cancer predisposition syndromes (CPSs) were rarely established for children with cancer. This nationwide, population-based study investigated how frequently children with cancer had or were likely to have a CPS.

methodsChildren (0-17 years) in Denmark with newly diagnosed cancer were invited to participate in whole-genome sequencing of germline DNA. Suspicion of CPS was assessed according to Jongmans'/McGill Interactive Pediatric OncoGenetic Guidelines (MIPOGG) criteria and familial cancer diagnoses were verified using population-based registries.

results198 of 235 (84.3%) eligible patients participated, of whom 94/198 (47.5%) carried pathogenic variants (PVs) in a CPS gene or had clinical features indicating CPS. Twenty-nine of 198 (14.6%) patients harbored a CPS, of whom 21/198 (10.6%) harbored a childhood-onset and 9/198 (4.5%) an adult-onset CPS. In addition, 23/198 (11.6%) patients carried a PV associated with biallelic CPS. Seven of the 54 (12.9%) patients carried two or more variants in different CPS genes. Seventy of 198 (35.4%) patients fulfilled the Jongmans' and/or MIPOGG criteria indicating an underlying CPS, including two of the 9 (22.2%) patients with an adult-onset CPS versus 18 of the 21 (85.7%) patients with a childhood-onset CPS (p = 0.0022), eight of the additional 23 (34.8%) patients with a heterozygous PV associated with biallelic CPS, and 42 patients without PVs. Children with a central nervous system (CNS) tumor had family members with CNS tumors more frequently than patients with other cancers (11/44, p = 0.04), but 42 of 44 (95.5%) cases did not have a PV in a CPS gene.

conclusionThese results demonstrate the value of systematically screening pediatric cancer patients for CPSs and indicate that a higher proportion of childhood cancers may be linked to predisposing germline variants than previously supposed.

Indexed as

Germ-Line MutationAdolescentChildChild, PreschoolFemaleGenetic TestingHumansIncidenceInfantMaleMutation RateNeoplastic Syndromes, HereditaryWhole Genome Sequencing

Identifiers

PMID33332384
PMCPMC7787686
OpenAlexW3111109342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.